MeSH D014657 - vasculitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014657:
Vasculitis
D001025:Aortitis
0 Companies
0 Drugs
Success rate
D001167:Arteritis
0 Companies
0 Drugs
Success rate
D001528:Behcet syndrome
D009080:Mucocutaneous lymph node syndrome
D010689:Phlebitis
0 Companies
0 Drugs
Success rate
D011695:Iga vasculitis
0 Companies
0 Drugs
Success rate
D012790:Shwartzman phenomenon
0 Companies
0 Drugs
Success rate
D018366:Leukocytoclastic vasculitis cutaneous
0 Companies
0 Drugs
Success rate
D020293:Central nervous system vasculitis
0 Companies
0 Drugs
Success rate
D031300:Retinal vasculitis
0 Companies
0 Drugs
Success rate
D054853:Malignant atrophic papulosis
0 Companies
0 Drugs
Success rate
D055952:Cogan syndrome
0 Companies
0 Drugs
Success rate
D056647:Systemic vasculitis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
56%5/9
Phase 2
74%14/19
Phase 3
52%12/23
Approved: 1Overall Success rate: 21%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use